Aethlon Medical, Inc.AEMDNASDAQ
Loading
Year-over-year research & development expense growth
Latest
81.02%
↑ 355% vs avg
Percentile
P92
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
17.82%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 81.02% |
| Q3 2025 | -43.87% |
| Q2 2025 | -60.53% |
| Q1 2025 | 453.03% |
| Q4 2024 | -8.14% |
| Q3 2024 | -36.94% |
| Q2 2024 | -35.70% |
| Q1 2024 | 8.68% |
| Q4 2023 | -5.58% |
| Q3 2023 | -7.43% |
| Q2 2023 | 10.28% |
| Q1 2023 | 10.28% |
| Q4 2022 | -34.52% |
| Q3 2022 | -0.69% |
| Q2 2022 | -8.40% |
| Q1 2022 | 164.29% |
| Q4 2021 | -25.85% |
| Q3 2021 | -18.63% |
| Q2 2021 | -16.60% |
| Q1 2021 | 52.80% |
| Q4 2020 | -9.38% |
| Q3 2020 | 34.93% |
| Q2 2020 | 60.51% |
| Q1 2020 | 7.51% |
| Q4 2019 | -1.92% |
| Q3 2019 | -10.45% |
| Q2 2019 | 3.59% |
| Q1 2019 | -1.48% |
| Q4 2018 | 36.38% |
| Q3 2018 | -8.21% |
| Q2 2018 | 57.90% |
| Q1 2018 | -4.52% |
| Q4 2017 | -23.35% |
| Q3 2017 | 7.05% |
| Q2 2017 | -10.49% |
| Q1 2017 | -1.41% |
| Q4 2016 | -36.47% |
| Q3 2016 | 138.70% |
| Q2 2016 | -42.83% |
| Q1 2016 | 39.25% |